Second Sight Medical Products, Inc. is a medical device company that develops, manufactures and markets implantable visual prosthetics to restore some functional vision to blind patients. The Company�s product, The Argus II Retinal Prosthesis System (Argus II) treats outer retinal degenerations, such as retinitis pigmentosa (RP).It restores functional vision for people suffering from blindness. The Argus II System is approved in the United States by the Food & Drug Administration (FDA) and European Economic Area (CE Mark) and is available in some European countries. As of November 14, 2014, the Company�s Argus II System was implanted in about 90 patients in the United States, Canada, France, Italy, Germany, the Netherlands, Saudi Arabia, Spain, Switzerland and the United Kingdom. The Company is also developing another product for cortical stimulation, known as the Orion I visual prosthesis, to treat nearly all forms of blindness.